Race Mismatch in Ex Vivo Lung Perfusion Is Not Associated With Worse Survival After Lung Transplantation
Artificial Organs · 2026-11 · 50 (11) · 1626-1634
DOI: 10.1111/aor.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 04.10.2026. Verfasst von Neelesh Bagrodia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Perfusion, Organ Preservation. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Jewel and Frank Benson Family Endowment.
Abstract (Originalsprache)
Objective
To meet the growing demand of donor lungs, ex vivo lung perfusion (EVLP) is being used to further assess higher risk donor lungs. This study aims to identify the association of race mismatch between donor and recipient on survival in lung transplantation with EVLP.
Methods
The UNOS database was queried for all lung transplants evaluated with EVLP from 2/2018 to 3/2025. Recipients with age < 18, multi‐organ transplants, re‐transplants, or missing data were excluded. Transplants were stratified into those with race concordance (RC) and mismatch (RM) between recipients and donors. Kaplan–Meier methods with log‐rank tests were used to assess survival differences. A multivariable cox regression model was created using select variables.
Results
1246 lung transplant recipients were identified: 638 in the RC group, 608 in the RM group. RC recipients were predominantly White (92.2% vs. 55.9%), had higher incidence of former smoking history (63.2% vs. 54.3%), and lower lung allocation scores. RC donors were more frequently White (92.2% vs. 31.6%) and DCD (38.6% vs. 29.9%). Post‐operative outcomes were similar between both RC and RM groups, only treated rejection in the first year was significantly higher in the former ( p = 0.005). Unadjusted survival did not differ between the groups ( p = 0.27). On multivariate cox‐proportional hazard modeling, RM was not independently predictive of mortality (HR 1.16 95% CI: 0.92–1.46) while recipient ECMO was the strongest predictor of mortality (HR 2.68, 95% CI: 1.71–4.20).
Conclusions
For recipients who underwent lung transplantation following EVLP, race mismatch was not independently associated with mortality on adjusted analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- COPPER Laboratory, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
- Los Robles Regional Medical Center, Thousand Oaks, California, USA.
ORCID-Profile: Neelesh Bagrodia, Divyaam Satija, Casey T Walk, Kukbin Choi, Matthew C Henn, Asvin M Ganapathi, Bryan A Whitson
Förderung
- Jewel and Frank Benson Family Endowment
Zitieren
APA
Bagrodia, N., Cui, E. Y., Satija, D., Walk, C. T., Aly, A., Guo, A., Alvarez, A., Choi, K., Henn, M. C., Ganapathi, A. M., Gouchoe, D. A., & Whitson, B. A. (2026). Race Mismatch in Ex Vivo Lung Perfusion Is Not Associated With Worse Survival After Lung Transplantation. Artificial Organs, 50(11), 1626-1634. https://doi.org/10.1111/aor.70220
Vancouver
Bagrodia N, Cui EY, Satija D, Walk CT, Aly A, Guo A, et al. Race Mismatch in Ex Vivo Lung Perfusion Is Not Associated With Worse Survival After Lung Transplantation. Artificial Organs. 2026;50(11):1626-1634. doi:10.1111/aor.70220
BibTeX
@article{Bagrodia2026,
author = {Bagrodia, Neelesh and Cui, Ervin Y and Satija, Divyaam and Walk, Casey T and Aly, Ahmed and Guo, Aaron and Alvarez, Ammu and Choi, Kukbin and Henn, Matthew C and Ganapathi, Asvin M and Gouchoe, Doug A and Whitson, Bryan A},
title = {Race Mismatch in Ex Vivo Lung Perfusion Is Not Associated With Worse Survival After Lung Transplantation},
journal = {Artificial Organs},
year = {2026},
volume = {50},
number = {11},
pages = {1626--1634},
doi = {10.1111/aor.70220}
}
EUVIMED